BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 5576153)

  • 1. Mercurascan test in ischaemia of the heart muscle caused by permanent ligature of the coronary artery.
    Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
    Rev Czech Med; 1971; 17(1):11-5. PubMed ID: 5576153
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the therapeutic use of mercurascan (MSC). Part 1: Distribution of mercurascan in the body in experimental and clinical myocardial ischaemia.
    Málek P; Vavrejn B; Kolc J; Ratuský J
    Int J Clin Pharmacol; 1974 Dec; 10(4):266-72. PubMed ID: 4443131
    [No Abstract]   [Full Text] [Related]  

  • 3. Uptake of 203Hg-hydroxy-mercury-fluorescein in myocardial infarcts.
    Ramanathan P; Ganatra RD; Daulatram K; Sen PK; Blau M
    J Nucl Med; 1971 Sep; 12(9):641-3. PubMed ID: 5571890
    [No Abstract]   [Full Text] [Related]  

  • 4. [The mercury radioisotope scanning test in myocardial ischemia induced by ligation of the coronary artery].
    Málek P; Kolc J; Vavrejn B; Ratuský J; Kronrád L
    Cas Lek Cesk; 1970 May; 109(24):542-5. PubMed ID: 5447169
    [No Abstract]   [Full Text] [Related]  

  • 5. [Use of a new diagnostic and antiarrhythmic agent, mercurascan, in experimental myocardial infarct].
    Malek P; Vavreĭn B; Kolts I; Vrana M; Ratuskiĭ I
    Eksp Khir Anesteziol; 1975; (6):3-11. PubMed ID: 1234540
    [No Abstract]   [Full Text] [Related]  

  • 6. [Scintiscanning in myocardial infarct using "Mercuroscan"].
    Ballaira L
    Riv Crit Clin Med; 1968; 68():Suppl 6:947+. PubMed ID: 5747766
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies on the therapeutic use of mercurascan (MSC). Part 2: Antiarrhythmogenic and haemodynamic effect of MSC in experimental myocardial ischaemia.
    Málek P; Vrána M; Kolc J; Netusil M; Blazek Z
    Int J Clin Pharmacol; 1974 Dec; 10(4):273-82. PubMed ID: 4140846
    [No Abstract]   [Full Text] [Related]  

  • 8. Detection of myocardial infarction by in vivo scanning.
    Málek P; Vavrejn B; Ratuský J; Kronrád L; Kolc J
    Cardiologia (Basel); 1967; 51(1):22-32. PubMed ID: 5596757
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of fluorescence in the macroscopic delimitation of experimental acute myocardial ischemia before and after revascularization].
    Loisance D; Sadony V; Kaufman H; Sarton MT; Cachera JP
    Arch Mal Coeur Vaiss; 1973 Jun; 66(6):701-7. PubMed ID: 4199785
    [No Abstract]   [Full Text] [Related]  

  • 10. 43KCl: a new radiopharmaceutical for imaging the heart.
    Hurley PJ; Cooper M; Reba RC; Poggenburg KJ; Wagner HN
    J Nucl Med; 1971 Jul; 12(7):516-9. PubMed ID: 5092229
    [No Abstract]   [Full Text] [Related]  

  • 11. [Velocity of the selective accumulation of Mercurascan 203 in injured muscle and in the ischemic myocardium].
    Málek P; Vavrejn B; Ratuský J; Kronrád L; Kolc J
    Experientia; 1967 Aug; 23(8):649-51. PubMed ID: 6051694
    [No Abstract]   [Full Text] [Related]  

  • 12. Protective effect of Mercurascan after coronary artery ligation in the dog.
    Málek I; Kolc J; Mrhová O; Urbanová D; Málek P
    Eur J Cardiol; 1980; 12(1):55-62. PubMed ID: 7439234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Further advances in the topical diagnosis of ischemic myocardial lesions in vivo].
    Málek P; Vavrejn B; Ratuský J; Kolc J; Kronrád L
    Cas Lek Cesk; 1966 Nov; 105(47):1273-8. PubMed ID: 5979879
    [No Abstract]   [Full Text] [Related]  

  • 14. The anatomical-functional picture of the vessels in the ischaemic myocardium--a fluorescence investigation.
    Borodin YuI ; Polyansky BA; Bikbulatov ZT; Khryachkov VV
    Folia Morphol (Praha); 1982; 30(2):192-4. PubMed ID: 7118008
    [No Abstract]   [Full Text] [Related]  

  • 15. Mapping myocardial mass and regional coronary blood flow by external monitoring of 42K or 86Rb clearance.
    Love WD; Smith RO; Pulley PE
    J Nucl Med; 1969 Nov; 10(11):702-7. PubMed ID: 5824100
    [No Abstract]   [Full Text] [Related]  

  • 16. Ischaemia detecting radioactive substances for scanning cardiac and skeletal muscle.
    Malek P; Ratusky J; Vavrejn B; Kronrad L; Kolc J
    Nature; 1967 Jun; 214(5093):1130-1. PubMed ID: 6053080
    [No Abstract]   [Full Text] [Related]  

  • 17. [Complex effect of mercurascan on ischaemia-induced myocardial injury].
    Málek P; Kolc J; Vrána M; Kucerová V; Mrhová O; Vránová Z
    Cas Lek Cesk; 1975 Jun; 114(25):753-7. PubMed ID: 1157063
    [No Abstract]   [Full Text] [Related]  

  • 18. [Scintigraphic visualization of cardiac infarct. Experimental studies of the distribution of chloromedrin-Hg203 in the tissues].
    Pucci C; Ferri O; Augusti A
    Minerva Chir; 1971 Sep; 26(18):1011-23. PubMed ID: 5129423
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of mercury derivatives of fluorescein on the fibrillation threshold in experimental myocardial infarction.
    Málek P; Kolc J; Vrána M; Blazek Z
    Experientia; 1971 Mar; 27(3):273. PubMed ID: 5546638
    [No Abstract]   [Full Text] [Related]  

  • 20. Possibilities of scintigraphic detection of tumours and damaged tissues with the aid of radioactive mercury compounds.
    Petrboková I; Vavrejn B; Kronrád L
    Nucl Med (Stuttg); 1972 Nov; 11(3):247-53. PubMed ID: 4648965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.